Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias



Status:Completed
Conditions:Parkinsons Disease, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:March 2012
End Date:October 2013

Use our guide to learn which trials are right for you!

An Open-label Treatment Study to Evaluate the Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

This study is to evaluate long-term safety, tolerability and efficacy for AFQ056 in patients
who have completed an AFQ056A study in Parkinson's disease L-dopa induced dyskinesias
(PD-LID).


Inclusion Criteria:

- Patients who have completed a previous AFQ056A study or are eligible as defined in
the core study protocol

- Outpatients

- Patients who have a primary caregiver willing and able to assess the condition of the
patient throughout the study in accordance with protocol requirements

Exclusion Criteria:

- Atypical or secondary form of Parkinson's disease

- History of surgical treatment for PD including deep brain stimulation

- Advanced, severe, or unstable disease (other than PD)

- History of malignancy

- Evidence of dementia

- Untreated/ineffectively treated mental disorders

- Treatment with certain prohibited medications

- Abnormal lab values or heart abnormalities

- Pregnant or nursing women
We found this trial at
4
sites
Milwaukee, Wisconsin 53209
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Englewood, Colorado 80112
?
mi
from
Englewood, CO
Click here to add this to my saved trials
?
mi
from
Innsbruck,
Click here to add this to my saved trials
Kansas City, Kansas 66160
?
mi
from
Kansas City, KS
Click here to add this to my saved trials